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INTRODUCTION 
 In the early 1980s as the systemic manifestation of the AIDS were first, 
described, investigators realized that human immunodeficiency virus type 1 infection 
could affect the nervous system at every level. With HIV infection increasing by the 
day in our society, neurological manifestations in HIV infection is not an uncommon 
occurrence. These neurological disorder occur either as a direct consequence of the 
HIV infection itself, or, as a immunological complication of the infection, or, as 
opportunistic infection of CNS, or, as a result of adverse reaction to antiviral agents. 
 Neurologic disease may manifest at any stage of the infection i.e. from the 
stage of Seroconversion to full fledged AIDS. In retrospective analysis it was 
observed that 10% of Patients with AIDS have neurological symptoms during the 
course of the illness, and 75% have evidence of CNS neuropathology at autopsy1,2,3.  
 Neurological manifestations of HIV consists of CNS complications caused 
directly by HIV, and include cognitive disorders and other CNS disease such as 
myelopathy and the demyelinating neuropathies, and the secondary disorders caused 
by opportunistic infections, neoplasm, cerebrovascular events, as also the effects of 
metabolic derangements and medications. 
 Considering the protean manifestations of neurological illness in HIV infected, 
an analysis of neurological manifestations in this subset of Patients was made. 
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AIM OF THE STUDY 
 To study the pattern of neurological manifestations in HIV infected subjects. 
 To study the correlation of neurological manifestations with CD4 count in these 
subjects. 
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REVIEW OF LITERATURE 
 Nervous system disease was not widely noted in the early years of  
HIV epidemic. However it is now recognized that almost every part of the nervous 
system can be affected not only by opportunistic infections but directly or indirectly 
by HIV itself. 
 Neurologic disease is the first manifestation of symptomatic HIV infection in 
roughly 10 to 20% of persons, while about 30 to 40% of patients with advanced HIV 
disease will have clinically evident neurologic dysfunction during the course of their 
illness1,2. The incidence of subclinical neurologic disease is even higher, autopsy 
studies of patients with advanced HIV disease have demonstrated pathologic 
abnormalities of the nervous system  in around 75% of cases2. 
PATHOGENESIS 
 HIV crosses the blood brain barrier and enters the nervous system, early, 
probably concomitant with initial systemic infection4. The virus has been cultured 
from brain, nerve and cerebrospinal fluid from persons at all stages of HIV diseases 
including those without neurologic signs or symptoms5. Positive HIV – 1 cultures in 
CSF do not predict the presence or development of Neuro AIDS. It depends on a 
number of factors such as degree of immunosuppression and  the molecular biology of 
the viral strain, particularly its neurovirulence. 
 HIV – 1 associated neural damage is most likely initiated by HIV – 1 infected 
and primed macrophages / microglia. The HIV – 1 infected macrophage appears to be 
hyperesponsive to activation stimuli. Both viral proteins and cellular products of  
HIV – 1 infected cells may act as neurotoxins. A complex interaction occurs between 
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HIV –1 infected macrophages / microglia and astrocytes that results in the release of 
proinflammatory cytokines TNF - α and IL – IB as well as PAF and arachidonic acid 
metabolites6. Ultimately, the cytokines upregulate HIV –1 infection in the brain. 
Although these products amplify neurotoxic and glial proliferatory effects of a small 
number of productively HIV – 1 infected cells, astrocytes produce TGF – B and 
macrophages release IL – 10, which independently downregulate proinflammatory 
cytokines. This may lead to chronic low – level inflammation, viral replication and 
tissue pathology. 
 Lastly, it appears that excitotoxic mechanism may underlie neuronal injury and 
death in HIV – 1 encephalitis7. This final common pathway could be the result of 
production or release of excessive amounts of glutamate, PAF or NMDA agonists 
such as quinolate7. 
PRIMARY HIV INFECTION OF THE BRAIN 
HIV – 1 associated dementia complex 
 HIV – 1 associated dementia complex has been variously called AIDS 
dementia complex, AIDS encephalopathy. HIV encephalitis, and multinucleated giant 
cell encephalitis. 
 With uncommon exceptions dementia is a late complication of HIV disease, 
occurring in the setting of systemic symptoms and severe immunosuppression8. 
Cognitive impairment develops in about 30% of people with advanced AIDS and 
frank dementia in 15 to 20%, with an annual incidence after AIDS of approximately 
7%9. There have been reports of dramatic decline in the frequency of HIV dementia 
after 1987, related to the earlier and more widespread use of antiretrovirals.  
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 Though there is some variability among patients, the syndrome is sufficiently 
stereotypic to be relatively easily recognized, particularly in a patient who is well 
known to the observer. In adults, the clinical manifestation of HIV dementia suggests 
predominantly subcortical involvement, at least initially.  
 Typical symptoms include increasing forgetfulness, difficulty with 
concentration, loss of libido, apathy, inertia and waning interest in work and hobbies 
resulting in social withdrawal. Occasionally agitation or mania may be the initial 
manifestation. Generalized seizures can also occur as a manifestation of HIV 
dementia, however, they are usually not refractory and, in many cases, may be 
triggered by medications or illicit drugs. 
 Neurologic examination is often normal in the early stages of HIV dementia, 
although there may be demonstrable impairments of rapid eye and limb movements 
and diffuse hyperreflexia. As HIV dementia progresses, increased tone develops, 
particularly in the lower extremities and is usually associated with tremor, clonus, 
frontal release signs and hyperactive reflexes. Terminally, the patient is bed bound, 
incontinent, abulic or mute with decorticate posturing10. 
 Price and Brew10 have devised a staging system for HIV dementia that is 
widely used in both clinical and research areas. The scale combines functional impact 
of both cerebral and spinal cord dysfunction. This clinical staging system correlates 
well with performance on psychomotor speed measures and is useful to track 
progression and response to therapy. CT or MRI scans of the brain may be normal, but 
in setting of severe dementia the usual finding is diffuse atrophy and, on MRI, patchy 
or diffuse abnormal signal in the white matter on T2 - weighted images11.  
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Severity Scales of Dementia 
Stage Dementia 
0 Normal mental and motor function. Neurological signs are within the 
normal age - appropriate spectrum.  
0.5 Equivocal or subclinical: Absent, minimal, or equivocal symptoms 
without impairment of work or capacity to perform ADL. Examination 
may be normal mildly abnormal; signs may include reflex changes 
(e.g. generalized increase in deep tendon reflexes with active jaw jerk, 
snout or glabellar sign) or midly slowed ocular movements, but without 
clear slowing of extremity movements or loss of their dexterity or 
strength.  
1 Mild: Able to perform all, but the more demanding aspects of work or 
ADL but with unequivocal evidence (symptoms or signs including 
performance on neuropsychologic testing) of intellectual or motor 
impairment. The abnormal motor signs usually include slow or clumsy 
movements or extremities. 
2. Moderate: Able to perform basic activities of self care at home but cannot 
work or maintain more demanding aspects of daily life (e.g. maintain 
finances, read text more complex than a tabloid newspaper)  
3 Severe: Major intellectual incapacity (cannot follow news or personal 
events, cannot sustain complex conversation, considerable slowing of all 
output or motor liability.  
4 End Stage: Nearly vegetative. Intellectual and social comprehension and 
output are at a rudimentary level. Nearly or absolutely mute. 
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Aseptic meningitis  
 Bredesen et al12 first reported 15 homosexual patients with aseptic meningitis. 
Levy et al2 evaluated a total of 352 patients with AIDS and found two patients with 
aseptic meningitis.  
 In the setting of acute primary infection patients may experience a syndrome of 
headache, photophobia, and meningismus. Cranial nerve involvement may be seen, 
predominantly cranial nerve VII, but occasionally V and / VIII involvement. CSF 
findings include a lymphocytic pleocytosis, elevated protein level and normal glucose 
level. This syndrome, which cannot be clinically differentiated from other viral 
meningitis, usually resolves spontaneously within 2 to 4 weeks, however, in some 
patients it may become chronic1,2,12. 
Neuromuscular disorders 
 A wide range of peripheral nervous system disorders develop in patients with 
HIV infection, leading to pain, sensory symptoms, and muscle weakness. Both 
primary HIV - 1 associated nerve disorders and those secondary to opportunistic 
processes are well described. In addition, antiretroviral therapies such as ddI, ddC and 
d4T may cause or exacerbate peripheral neurophathies13. 
 Four types of neuropathy are important to recognize, either because of their 
high prevalence or their therapeutic implications, or both. They are 
1. Distal symmetric polyneuropathy (DSPN) 
2. Mononeuropathy multiplex  
3. Inflammatory demyelinating polyneuropathy 
4. Progressive lumbosacral polyradiculopathy  
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Depending on the study population and the method of case ascertainment, 
clinical, electrophysiologic or pathologic evidence of peripheral neuropathy is present 
in about one - third to nearly 100% of patients with advanced HIV disease14. The 
incidence of neuropathy increases with declining CD4 cell count and advancing 
systemic HIV disease. Toxicity of the therapeutic drugs, notably dideoxyinosine (ddI), 
dideoxycytidine (ddC) and stavudine (d4T), is responsible for a increasing number of 
cases of neuropathy or for their progression. 
Distal symmetric polyneuropathy  
 Distal symmetric polyneuropathy was initially described in patients with AIDS 
by Snider et al1 and its clinical and pathological features have been further 
characterized by numerous investigators15. DSP may be diagnosed in >30% of patients 
with AIDS, after other recognized causes for polyneuropathy are excluded. DSP is 
usually associated with late stages of HIV disease, as indicated by the presence of 
opportunistic infections and significant wasting in the majority of patients with DSP15.  
 The major presenting symptoms of DSP are numbness, distal paraesthesias and 
dysthesias, usually beginning in the lower extremities. A complaint of burning feet is 
reported by 23-100% of patients with AIDS evaluated for DSP in different series15. 
The upper extremities may be affected in a distal and symmetrical fashion later in the 
course of DSP. Muscle weakness is not a prominent symptom of DSP and generally 
occurs only late in the disease.  
 The most common signs of DSP in AIDS are depressed or absent reflexes at 
the ankles, relative to the knees15. The presence of hyperactive knee reflexes and 
depressed ankle reflexes may indicate concurrent myelopathy and neuropathy which is 
a common association in HIV infected individuals16. Vibratory thresholds are 
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increased, and pinprick and temperature are reduced in a stocking and glove 
distribution, whereas joint position sensation is relatively normal. Weakness is 
generally restricted to intrinsic foot muscles15, unless DSP is very advanced, or other 
neurologic disorders are also present.  
 Several studies have demonstrated that mean sural nerve conduction velocity or 
amplitude is significantly reduced in HIV seropositive patients as compared with 
controls. Small or absent small nerve action potentials are the most common 
abnormalities in patients with DSP, although in occasional patients with DSP normal 
sural responses have been reported. Needle EMG may demonstrate signs of active or 
partial denervation with reinervation in distal leg muscles.  
Mononeuropathy multiplex 
 In 1985, Lipkin et al17 first described the occurrence of inflammatory 
neuropathy in 12 homosexual patient with lymphadenopathy syndrome, of whom nine 
presented with multiple, asymmetrical nerve involvement.  
 Patients with MM have asymmetric or proximal involvement of peripheral 
nerves and preservation of tendon reflexes in asymptomatic distributions. The typical 
neurologic presentation includes multifocal sensory and motor abnormalities in the 
distribution of cutaneous nerves, mixed nerves and nerve roots17. Cranial neuropathies 
are also a frequent feature of MM17. 
 Although signs of focal or asymmetric multifocal axonal lesions are most 
typical in MM13 electrodiagnostic abnormalities may be diffuse and symmetrical, 
similar to DSP or may indicate primary demyelination, with slowing of NCV and 
conduction block17.  
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Inflammatory demyelinating polyneuropathy  
 Acute IDP (AIDP) and chronic IDP are most common in patients who are HIV 
seropositive and otherwise asymptomatic18. Several investigators have reported IDP 
upto one third of HIV infected patients referred for evaluation of peripheral 
neuropathy18 whereas others have found a much lower incidence. 
 AIDP is characterized by rapidly progressive weakness in distal and proximal 
muscles of two or more limbs associated with generalized areflexia. Occasionally, 
bilateral facial weakness may be the presenting symptom. The clinical progression of 
AIDP is usually rapid and reaches its peak within the first 4 weeks of neurologic 
illness, with involvement of respiratory muscles in the most severe cases. CIDP is 
distinguished by a more slowly progressive clinical course that may be monophasic or 
relapsing over several months18.  
 Electromyography typically shows signs or denervation in clinically weak 
muscles. CSF protein is usually elevated and, unlike the demyelinating neuropathies 
in the general population a mononuclear pleocytosis of upto 50 cells / mm3 sometimes 
occurs19.  
Progressive polyradiculopathy  
 Since PP was first reported by Eidelberg et al in 1985, it has been increasingly 
recognized as an alarming complication of AIDS20. The disorder is uncommon being 
reported in fewer than 2% of HIV seropositive patients referred for neurological 
consultation. Its rapidly progressive course and potentially good response to early 
therapy demand prompt diagnosis and treatment20. PP due to CMV infection occurs in 
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the setting of advanced systemic HIV disease in patients with very low CD4 cell 
counts (<50 cells / mm3) 19.  
 The clinical presentation of PP in characterized by radiating pain and 
parasthesias in the cauda equina distribution, followed by rapidly progressive flaccid 
paraparesis, lower extremity areflexia and mild sensory loss and sphincter 
dysfunction. The upper extremities may be involved late in the course of 
polyradiculopathy. The CSF findings in most patients with progressive 
polyradiculopathy are characterized by marked polymorphonuclear pleocytosis, 
elevated protein and cultures are positive for CMV in about half of the patients. The 
most prominent electrophysiologic abnormalities in PP are widespread denervation in 
lower extremity and lumbar paraspinal muslces, accompanied by abnormal late 
responses in affected distributions20. In most cases PP has a poor prognosis if 
untreated, with a mortality rate of nearly 100% and a mean duration of illness from 
onset of neurologic symptoms to death ranging from 2 to 30 days. 
Myopathy 
 Numerous cases of HIV associated myopathy were reported by several 
groups21,22. The predominant presenting symptom of myopathy is slowly progressive 
muscle weakness, typically characterized by difficulty in rising from a chair or 
climbing stairs21. Myalgia is present in 25 to 50% of affected patients21. However, 
myalgia is a nonspecific symptom in HIV infected individuals and is insufficient for 
diagnosis of myopathy even in the presence of elevated creatine kinase levels22. 
Electromyography of clinically weak muscles show fibrillation potentials, positive 
sharp waves, complex repetitive discharge, and a full recruitment of small, short 
duration motor unit action potentials.  
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Spinal cord disorders 
Vacuolar myelopathy  
 The most common spinal cord disease complicating HIV infection is HIV 
associated vacuolar myelopathy16. The pathologic finding of noninflammatory 
vacuolation of myelin, particularly in the lateral and the posterior columns of the 
spinal cord, characterizes VM. Upper thoracic cord is affected most commonly, but 
cervical pathology is well described and occasionally diffuse cord changes are seen16. 
 The clinical features of HIV-1 related VM have been systematically studied. In 
an autopsy based clinicopathological correlation, Dal Pan et al16 found that 15 of 56 
patients with pathologically confirmed VM had clinical evidence of myelopathy. Mild 
to moderate limb weakness were present in all cases, with severe weakness limited to 
only the most advanced cases. Knee hyperreflexia was common as were lower limb 
spasticity (eight of 15, 53%) and gait spasticity (60%). A sensory ataxia was seen in 
20% of cases. A coexistent distal sensory neuropathy with ankle areflexia or 
hyporeflexia was also common (eight of 15,53%). A discrete thoracic sensory level 
was seen in two of 15 cases (13%). Vibration and position sense loss were common. 
Bowel and bladder dysfunction were seen in only one case. In all cases, the 
development was slowly progressive, with onset of symptoms ranging from 3 to 16 
weeks before the diagnosis of myelopathy. The development of symptomatic 
myelopathy is more frequent in patients with pathologically more severe VM.  
Other causes of myelopathies  
Infectious myelopathy  
 Though the noninflammatory VM is the most common cause of spinal cord 
disease in HIV-1 infection, there have been several case reports of myelopathy 
attributed to other infectious agents.  
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 HAM also called tropical spastic paraparesis, has been reported in HIV 
patients23 due to HTLV-1 virus. 
 Other infectious agents resulting in acute myelopathy in HIV patients include 
Toxoplasma gondii, Treponema pallidum, Herpes viruses and Mycobacterium 
tuberculosis.  
 Neoplastic causes of myelopathy due to spinal cord compression from 
lymphomatous metastasis have been sporadically reported.  
INTRACRANIAL OPPORTUNISTIC INFECTIONS 
Toxoplasma gondii 
 Toxoplasma gondii is an ubiquitous obligate intracellular protozoan found 
throughout the world. For patients with acquired immunodeficiency syndrome, it is 
the most common cause of focal central nervous system infection. Its incidence 
appears to be declining among patients receiving Pneumocystis carinii prophylaxis. 
Earlier reports described frequencies 3 to 40% reflecting considerable regional 
variation in exposure to the parasite1,2,24. 
 In patients with AIDS, over 95% of toxoplasmic encephalitis is due to 
reactivation of a chronic (latent) infection24. For most HIV infected patients, 
toxoplasmic encephalitis (TE) develops when the CD4 + T lymphocyte count  
(CD4T count) falls below 100/mm3. 
 Toxoplasmosis in the AIDS patient is most frequently manifested by 
toxoplasmic encephalitis, usually alone or less frequently as part of multiorgan 
infection. Isolated organ involvement without CNS disease is uncommon. TE most 
frequently presents (50 to 89%) with a subacute onset of neurological deficits with or 
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without evidence of generalized cerebral dysfunction. Less often (15 to 25%), seizures 
may be the initial manifestation. The clinical presentation varies from an insidious 
process evolving over several weeks to a more acute, at times fulminant course. 
Abnormalities associated with focal lesions include hemiplegia, hemisensory loss, 
dysphasia, aphasia, movement disorders (hemichorea and hemiballismus), ataxia, 
diplopia, cranial nerve palsies, cerebellar tremor, severe localized headache, 
Parkinsonian syndrome, and intractable hiccoughs. Abnormalities attributable to 
generalized cerebral dysfunction include lethargy, confusion, coma and global 
cognitive impairment similar to AIDS related dementia24. 
 Almost 100% of AIDS patients with TE will have detectable IgG by Sabin 
Feldman Dye test or immunofluoroscence assay. The ELISA IgM is more sensitive 
and specific than IFA, but both tests report high false positive results. 
 CT scan of the brain usually shows multiple ring enhancing lesions with 
predilection for cortex and deep gray matter structures as the basal ganglia. The 
cerebellum and brainstem are less commonly involved. MRI is more sensitive than the 
CT, which can understimate the number of lesions.  
Cryptococcus neoformans 
 Cryptococcus neoformans is the most common fungal infection of the CNS and 
usually present as a subacute meningitis25,26. Cryptococcal disease occurs in 1.9% to 
11.6% of patients with AIDS25,26.  
 Clinical manifestations can be remarkably benign, with vague malaise or 
nausea alone. More commonly headache and fever are the presenting features. An 
acute confusional state can be seen, as can cranial nerve palsies. More specific 
 15
symptoms of meningeal involvement such as stiff neck, photophobia, nausea and 
vomiting are present in only 20 to 40% of patients25,26. 
 The CT of the head is normal or shows cerebral atrophy in 75 to 90% of cases. 
Nonenhancing and contrast enhancing lesions presenting as either nodular or ring like 
patterns, particularly in the basal ganglia are seen25,26. CSF can be normal or show 
mononuclear pleocytosis, elevated protein, low glucose and high opening pressure. 
India ink preparations are positive in 72 to 88% of patients. Determination of CSF 
Cryptococcal Antigen (CRAG) titre is essential because this may be the only CSF 
abnormality; latex agglutination of CSF for Cryptococcal antigen has a sensitivity of 
91% to 100%. A positive CSF culture is the definitive diagnostic test for Cryptococcal 
meningitis and the main entry criteria in published series. Being the gold standard, its 
sensitivity approaches by definition 100%25,26.  
Other Fungal Infections 
 In addition to cryptococcal meningiits, other CNS fungal infections such as 
Histoplasmosis, Coccidioidomycosis, Blastomycosis and Aspergillosis have been 
reported.  
Progressive multifocal leucoencephalopathy 
 PML is a demyelinating disease of the central nervous system that results from 
infection of oligodendrocytes with JC virus, a papovavirus27. It affects approximately 
4 to 8% of patients with advanced HIV disease27. It is a subacute or chronic 
progressive illness most often characterised by focal neurologic findings such as 
hemiparesis, gait abnormalities and visual field cuts, and mental status and personality 
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changes. Dementia, encephalopathy and coma can occur with fulminant disease. 
Seizures are uncommon, but not rare. 
 Radiographic imaging provides the strongest support in diagnosing PML but 
presently confirmation requires brain biopsy. Affecting the white matter, generally not 
enhancing with contrast and exhibiting no mass effect, the hypodense lesions of PML 
on CT of the brain reveal areas that may have a "scalloped" appearance as a result of 
the subcortical fibers lying beneath the cortex28. The lesions have a predilection for 
the frontal and parieto-occipital lobes, may occur virtually anywhere. The brainstem 
or cerebellum may be solely involved in upto 15% of cases28.  
 Demyelination observed with HIV associated dementia may be 
radiographically indistinguishable from that of PML. Clinically however PML is 
associated with focal neurological disease and is much more rapidly progressive. 
Radiographic distinctions include a greater propensity of lesions to involve the 
subcortical white matter, its hypointensity on T1 weighted images and its rare 
enhancement28.  
 Routine CSF evaluation is nondiagnostic and is usually normal or reveals only 
nonspecific changes such as mild pleocytosis or protein elevation. CSF PCR detection 
of JC virus DNA has become the successful tool in the diagnosis of PML.  
Viral encephalitis 
 
 
 Herpes simplex virus typically cause acute hemorrhagic necrotizing 
encephalitis with predilection for subfrontal and medial temporal lobes29. In AIDS 
patients HSV encephalitis presents with typical clinical features which include 
headache, fever and variable combinations of seizures, behavioral and cognitive 
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changes, focal signs and ultimately obtundation. Definitive diagnosis often requires 
brain biopsy, but CSF PCR would reduce the need for tissue diagnosis29. 
Herpes Zoster virus 
 Herpes zoster virus infection of the nervous system may result in radiculitis. 
characterized by painful vesicular cutaneous eruptions involving one or several 
dermatomes2,3. It also causes subacute encephalitis in a number of AIDS patients with 
clinical features which include lethargy, confusion and variable focal findings 
including cranial neuropathies30. Myelitis due to herpes zoster had been described in 
immunocompromised patients including AIDS patients with clinical features such as 
subacute progression of motor weakness, sensory deficits and sphincter disturbances 
in varying combinations that evolve over weeks. 
Cytomegalovirus 
Of the human herpes viruses, CMV is the major cause of morbidity in AIDS 
patients and is frequently the cause of death. 
 CMV encephalitis presents as a subacutely progressive diffuse encephalitis 
evolving over several weeks and characterized by confusion and imparied sensorium, 
with variably associated cranial neuropathies, ataxia and motor weakness31. 
Alternatively the presentation may result in focal neurological symptoms 
corresponding to the location of discrete parenchymal lesions, which may progress to 
a more diffuse encephalitis31. Signs of meningitis may be present31. Median survivals 
following neurological presentation in small series are about a month. 
Several recent retrospective studies suggest that polymerase chain reaction 
amplification technique to detect CMV specific DNA in CSF samples may be a highly 
sensitive and specific diagnostic test for CMV infection of the CNS. 
Necrotizing myelitis attributable to CMV in AIDS presents has been reported 
by number of authors32. Clinical features include paraplegia, urinary retention  and 
hypoesthesia, typical of myelopathy.  
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CMV poly radiculomyelitis in patients with AIDS presents subacutely with 
paraesthesias or pain, progressive hypotonic weakness, areflexia and variable sensory 
deficits ascending from the lower extremities to involve spinal cord, upper extremities 
and cranial nerves in some patients32. 
Neurotuberculosis 
 Tuberculosis has become an increasingly common problem in HIV – infected 
persons and extrapulmonary involvement is seen in 60% of cases. In patients with 
HIV – related tuberculosis positive CSF cultures are obtained in 3% to 10% of the 
time33. Given the difficulty of culturing this organism from CSF, this implies an even 
higher rate of CNS complication and typically presents as a subacute meningitis. 
Headache and fever are noted in the majority of cases with encephalopathy, 
particularly if there is elevated intracranial pressure. Cranial nerve abnormalities and 
frank meningeal signs are less common. The CSF analysis usually demonstrates a 
lymphocytic pleocytosis with a total cell count in the range of 200 to 500/mm3, 
hypoglycorrhachia is also commonly observed. Two large series suggest that the 
clinical presentation, overall CSF profile and prognosis are identical in patients with 
and without HIV infection. The only difference between seropostive and seronegative 
patients is an increased incidence of intracerebral mass lesions in the HIV infected 
group (60% versus 14%).  
 Isolated CNS tuberculomas may present without concomitant tuberculous 
meningitis. Their characteristics on cerebral imaging studies have varied; some 
appears as ring enhancing lesions while others are hypodense and nonenhancing 
lesions. Anecdotal evidence suggests that CNS tuberculosis may be more common 
when initial antituberculous therapy has failed, when there is a relapse of disease or 
when multidrug resistant organisms cause disease. Diagnosis of CNS tuberculosis is 
still difficult because of the lack of rapid diagnostic tests. Polymerase chain reaction 
based techniques are used for their purpose. Criteria used for diagnosis of TBM were 
those previously established by Ogawa et al34. A definite diagnosis of TBM was made 
by isolation of M. tuberculosis from the CSF or the presence of TBM was established 
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by pleocytosis of the CSF and negative bacterial and fungal cultures (including the 
determination of bacterial antigens and cryptococcal antigen) and at least one of the 
following 1) a positive tuberculin skin test; 2) evidence of tuberculosis outside the 
CNS or previous active tuberculosis; 3) CSF glucose levels less than 2.2 mmol/L 
(40mg/dl); and (4) CSF protein levels greater than 0.60g/l. 
 Nontuberculous mycobacterial CNS infections due to Mycobacterium avium 
complex and Mycobacterium kansasii have also been described. 
Bacterial infections 
 Pyogenic bacterial infections have been increasingly noted over the course of 
the HIV epidemic and these infections may precede the onset of severe 
immunodeficiency35. Neurological infection with pyogenic bacteria such us 
pneumococci and nonpyogenic bacteria like Listeria have been reported though it 
occurs as a very rare event in HIV patients. 
NEOPLASMS 
Primary CNS Lymphoma 
 The first reports of PCNSL in HIV infected patients were published with the 
initial description of AIDS in 1982. Recently, there has been a dramatic increase in the 
incidence of PCNSL in association with AIDS. It is estimated that 1% to 2% of all 
HIV infected patients will develop PCNSL36. Epstein Barr virus has been implicated 
as  causative for both systemic and primary CNS lymphoma in association with AIDS 
or other immunocompromised States. The prevalence of EBV in AIDS-associated 
PCNSL has been reported to range between 94% and 100%37. 
 Unlike systemic NHL which can occur at any stage of HIV infection, PCNSL 
typically occurs in profoundly immunocompromised patients with CD4+ T -  
lymphocyte counts below 50cells/mm3 .   Alteration in the level of consciousness and 
focal neurological deficits are the most common presenting signs of PCNSL. Seizures  
occur in 23% of AIDS patients with PCNSL while cranial nerve deficits are evident in 
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13%. Signs of increased intracranial pressure are less common. The major difference 
in presentation between AIDS and non-AIDS related PCNSL are the high prevalence 
of B symptoms and the shorter duration of symptoms (days to weeks versus months) 
for patients with HIV related tumors. 
 Although no radiological finding is pathognomic for PCNSL, some 
radiological features are suggestive of the diagnosis. A homogenously enhancing 
lesions in the central gray matter or corpus callosum is highly suggestive of PCNSL. 
Ring like lesions may occur in 5% to 10% of cases. Most lesions are adjacent to an 
ependymal or meningeal surface with varying degrees of edema and mass effect. 
About 50% to 60% of lesions are located peripherally in the hemispheric gray matter 
or adjacent white matter. Another 25% of the lesions will be found in the deep midline 
structures of the septum pallucidum, basal ganglia or corpus callosum. 
Kaposi's sarcoma 
 CNS involvement by Kaposi's sarcoma is distinctly unusual. Common signs 
and symptoms include cranial nerve palsies and polyradiculopathy and less commonly 
myelopathy due to epidural metastasis with spinal cord compression. 
Intraparenchymal mass lesions are uncommon2 . 
MISCELLANEOUS 
Cerebrovascular complications 
 HIV infected patients are at increased risk for cerebral infarction. A large study 
of patients  with AIDS (n=1,286) found 1.6% to have cerebrovascular complications38. 
There is a broad spectrum of etiologies, but in many cases the pathogenesis of this is 
unclear. Cerebral granulomatous angitis due to inflammation in the walls of large and 
medium sized vessels can result in thrombosis and infarction39. Both intracerebral and 
leptomeningeal arteries may be involved. Varicella zoster infection as well as syphilis 
may produce cerebral infarction. Nonbacterial thrombotic endocarditis also may be 
responsible in a number of cases. 
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 CT and MRI may show the sequelae of cerebrovascular disease, including 
parenchymal haemorrhage, infarction, subarachnoid harmorrhage, and  
communicating hydrocephalus. Hypodensity is seen on CT, involving both gray and 
white matter, conforming to a vascular distribution. MRI often demonstrated 
infarction before detection by CT, with increased signal seen on proton density and 
T2WIs. Enhancement of arterial structures on MRI may indicate sluggish flow and 
may be an early  sign of infarction39. 
Bell's palsy 
 Cranial neuropathies are encountered frequently in HIV-1 infection while some 
patients may develop a cranial neuropathy in the context of a generalized neuropathy, 
others have developed isolated cranial neuropathies. The most common reports have 
been facial nerve palsy40. An acute lower motor nerve facial palsy, occurs frequently 
especially in HIV seropositive individuals who are otherwise healthy or who have any 
constitutional symptoms, such as weight loss, fever or thrush. Facial palsy may also 
occur during acute aseptic meningitis. Although some of the cases have demonstrated 
clear evidence of axonal damage, in others it is not clear whether these cases represent 
central involvement of the facial nerve nucleus, such as may occur in aseptic 
meningoencephalitis or cranial nerve inflammatory neuropathy per se. 
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MATERIALS AND METHODS 
PLACE OF THE STUDY 
 This study was conducted at the Government General Hospital, Chennai. 
Patients admitted to the wards of the institute of internal medicine and neurology 
wards were subjects of the study. 
PERIOD OF STUDY 
 APRIL 2005 - AUGUST 2006 
DESIGN 
 Prospective Randomised  cross sectional study. 
METHODOLOGY 
 HIV patients admitted at Government General Hospital were Chosen for the 
study, Random selection of patients were made in whom a detailed history and clinical 
evaluation which included the mini mental score (MMSE) was done, after an 
informed consent from the patient or relative. 
 The following investigation were done to all patients studied (i.e), when tested 
positive for HIV. 
1. Complete blood count. 
2. Renal function test (Sugar, Urea, Creatinine and Electrolytes) 
3. Liver Function Test (Bilirubin, AST, ALT, SAP, Albumin) 
4. Chest X-ray - P.A View 
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All patients with neurological systems were individualised and were subjected 
to the investigation listed based on clinical findings. 
1. C.S.F. 
2. CT Brain 
3. MRI Brain 
4. Nerve Conduction Study 
5. Creatinine Phosphokinase  
6. Electro Encephalogram (EEG) 
7. VDRL 
 
METHODOLOGY  OF INVESTIGATION 
 HIV Serology was done using Microlisa Kit.  
CD4 count were done with Facs Count (Automated Counter) manufactured by 
Becton and Dickinson. 
Tests were done in a single laboratory by the same person, no intrpersonal error 
was possible. The VCTC laboratory in our college in a laboratory identified by 
NACO. 
EXCLUSION CRITERIA 
 Immuno Compromised state due to any other cause. 
LIMITATIONS 
• Culture and PCR for mycobacterium could not be done. 
• Viral Serology was done only in selected patients. 
 24
RESULTS AND OBSERVATIONS 
INCIDENCE 
 32 Patients had neurological manifestations among the 100 Patients studied. 
The incidence of neurological manifestations in HIV infection, in this study is 32% 
SEX DISTRIBUTION 
 Of the 100 Patients studied 75 were male and 25 were Female. Among the 75 
males, 29 had neurological manifestations and of the 25 Females, 3 had neurological 
Symptoms. 
TABLE NO.1 - shows the sex distribution in this study 
Sex Positive Negative Total 
Male 29 
38.7% 
46 
61.3% 
75 
75% 
Female 3 
12.0% 
22 
88.0% 
25 
25% 
 
AGE DISTRIBUTION  
TABLE NO.2 - shows the age distribution in this study 
Age in Years Positive Negative Total 
<30 5 
25% 
15 
75% 
20 
31-40 19 
31.6% 
41 
68.3% 
60 
>40 8 
40.0% 
12 
60.0% 
20 
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 Majority of the patients in our study were between 31-40 yrs of age. Of the 60 
Patients, who were in the age group of 31-40, 19 (31.6%) had neurological symptoms. 
OCCUPATION 
TABLE NO.3 : shows the various occupations involved in this study 
Occupation Positive Negative Total 
Agriculture 3 
33.33% 
6 
66.66% 
9 
Daily Labourer 12 
37.50% 
20 
62.50% 
32 
Driver 5 
33.33% 
10 
66.66% 
15 
House Wife 3 
17.64% 
14 
82.35% 
17 
Mechanic 2 
50.008% 
2 
50.00% 
4 
Painter 4 
28.57% 
10 
71.42% 
14 
Unemployed 3 
100% 
0 3 
Student 
0 
1 
100% 
1 
Business 
0 
4 
100% 
4 
Accountant 
0 
1 
100 
1 
 
 In our study most of the patients were daily wage earners (32%) and 
neurological symptoms were also Common among these group of patients. 
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MODE OF TRANSMISSION 
 All Patients in this study group had Hetero Sexual behaviour as the mode of 
transmission. One Patient had I.V. drug usage as risk factor along with heterosexual 
behaviour. 
TABLE NO.4 
Mode of Transmission Frequency Percentage 
Hetro Sexual 100 100% 
Homo Sexual - - 
I.V. Drug  abuse  1 1% 
 
PRE - EXISTING INFECTION 
 Among 32 Patients who had neurological symptoms, 1 Patient had TB adenitis 
as co infection. 
TABLE NO.5 
Co Infection Frequency Percentage 
TBA 1 3.13% 
Nil 31 96.88% 
 
PHYSICAL ACTIVITY STATUS IN PATIENTS WITH NEUROLOGICAL 
SYMPTOM 
TABLE NO.6 
 Frequency Percentage 
Ambulatory  19 59.38% 
Working 9 28.13% 
Bed Ridden  4 12.50% 
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 19 Patients in the study group who had neurological manifestation were 
Ambulatory (i.e. able to do their daily activities but not working), 9 were working and 
4 were bed ridden. 
CLINICAL PRESENTATIONS 
 This table shows the various Clinical Presentations and their frequency in the 
Patients having neurological Manifestations. 
TABLE NO.7 
Clinical Presentation Frequency Percentage 
Headache 13 40.03% 
Altered Sensorium  14 43.75% 
Hemiplegia  4 12.50% 
Seizures  8 25.00% 
Paraperesis 4 12.50% 
Quadriperesis  1 3.13% 
Parasesthesias  2 6.25% 
Cerebellar Syndrome  2 6.25% 
Involuntary Movements 1 3.13% 
 
CHART - 1 : Shows various diseases presenting as Altered Mentation in this 
study 
 
 
 
 
 
 
 
 
 
 
 
ALTERED MENTATION
0 1 2 3 4 5 6 7
Tuberculous M eningtis
Pyogenic M eningtis
Cryptococcal M eningitis
M eningoencephalitis (Cause not determined)
Neurosyphilis
CVA
Cerebellar Syndrome
No of Patients
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CHART - 2 : Shows various diseases presenting as Headache  in this study 
 
 
 
 
 
 
 
 
 
 
 
 
CHART - 3: Shows various diseases presenting as Hemiplegia in this study 
 
 
HEADACHE
0 1 2 3 4 5 6 7
Tuberculous meningitis
Pyogenic meningitis
Multiple granuloma
AIDS dementia complex
Tuberculoma
Cryptococcal Meningitis
No of Patients
HEMIPLEGIA
0 1 2 3 4 5 6 7
Cerebrovascular accident
Tuberculous Meningitis
No of Patients
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CHART - 4 : Shows various diseases presenting as Seizures in this study 
  
 
 
 
 
 
 
 
 
 
 
CHART - 5  : Shows various diseases presenting as Paraparesis in this study 
 
 
PARAPARESIS
0 1 2 3 4 5 6 7
Guillian - Barre Syndrome
Neurosyphilis
HIV myelopathy
No of Patients
SEIZURES
0 1 2 3 4 5 6 7
Tuberculous meningitis
Seizure disorder
Tuberculoma
Pyogenic meningtis
Meningoencephalitis
(Cause not determined)
No of Patients
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DISEASE PATTERN 
 
Shows the disease patterns among patients who had neurological 
manifestations. 
TABLE NO.8 
Diagnosis Frequency Percentage 
Acute Flaccid Paralysis 1 3.13% 
AIDS Dementia Complex 1 3.13% 
Cerebellar Syndrome  1 3.13% 
Cryptococcal Meningitis  1 3.13% 
Cerebrovascular Accident 3 9.38% 
Guillian Barre Syndrome  2 6.25% 
HIV Myelopathy 1 3.13% 
Meningoencephalitis (Cause not determined) 1 3.13% 
Multiple Granuloma  1 3.13% 
Myopathy 1 3.13% 
Neurosyphils  1 3.13% 
Peripheral Neuropathy 2 6.25% 
Progressive Multifocal Leucoencephalopathy 1 3.13% 
Pyogenic Meningitis 2 6.25% 
Seizure Disorder 2 6.25% 
TB Meningitis 10 31.25% 
Tuberculoma 1 3.13% 
 
OUT COME 
TABLE NO.9 : shows the outcome in the study 
Out Come Frequency Percentage 
Expired  18 56.25% 
No. Improvement 9 28.13% 
Improved 5 15.63% 
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 18 Patients who had neurological manifestations in the study group expired 
(56.25%), 9 Patients showed no improvement (28.13%) and 5 Patients had 
improvement in their clinical condition. 
CD4 COUNT CORRELATION 
TABLE NO.10 
CD4 Count  
Mean SD 
Patient with Neurological 
Manifestation 179.19 113.16 
Patient without neurological 
Manifestation  225.03 134.58 
 
 CD4 count levels in Patients with neurological manifestations ranged from 9 
and 539 with an average of 179.19. The average CD4 levels in Patients without 
neurological manifestations was 225.03. There was no statistically significant 
difference between the two groups. (P>0.05) 
CD4 CORRELATION WITH MORTALITY 
TABLE NO.11 
Out Come 
CD4 
Mean 
Count 
SD 
Expired 108.38 41.65 
No Improvement 231.78 128.87 
Improved 268.60 110.94 
 
 The  mean CD4 Count of the patients who expired was 108.38. Mean CD4 
Count of the patients who did not improve and who improved were 231.78 and 268.60 
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respectively. There is a statistically significant correlation of CD4 count among 
patients who expired (P-0.003**). 
CD4 CORRELATION WITH TB MENINGITIS 
 There were 10 Patients diagnosed to have TB Meningitis. CD4  Count for one 
Patient was not done as the patient died before blood was taken for CD4 count. The 
mean CD4 count of patients with TB Meningitis in the study group was 120.88 and the 
mean CD4 count of patients who did not have any neurological manifestations was 
225.02. Statistically significant different of CD4 count was observed between the two 
groups. (P-0.025*). 
 
TABLE NO.12 
 No. of Cases Mean SD 
Patients with TB Meningitis  9 120.88 43.161 
Patients without Neurological 
Manifestation 
68 225.02 134.585 
 
MINI MENTAL SCORE 
 
TABLE NO.13 
MMSE 
 
Mean SD 
Patient with Neurological 
Manifestation 24.94 2.13 
Patient without neurological 
Symptoms  26.65 .84 
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 Mini mental Score of Patients with neurological symptoms was compared with 
those without neurological symptoms. Significant difference was observed in patients 
with neurological symptoms, P value being less than 0.001** 
FUNDUS  
 Fundus Examination was done for all co-operative patients. 
 6 patients had features of papilloedema and one patient had features of HIV 
Retinitis.  
CSF ANALYSIS  
CSF Analysis was done for 22 patients in the study. 
11 Patients had elevated proteins and predominant lymphocytes. 
5 Patients had normal CSF. 
2 had elevated proteins and acellular smear. 
2 had elevated proteins and predominant neutrophils. 
1 had elevated proteins and occasional lymphocytes and also had positivity for 
cryptococcus in India Ink preparation.  
CT BRAIN 
26 Patients in the study were subjected to CT Brain among which 3 patients 
had middle cerebral arterial territory infarct, 1 had left cerebellar hypodensity and 1 
had multiple calcified granulomata. 
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MRI 
 In this study 3 patients had MRI brain done for them. 1 had extensive white 
matter lesions suggesting PML, 1 had multiple ring enhancing lesions who was 
diagnosed to have Tuberculoma and other patient had features suggestive of normal 
pressure hydrocephalus. 
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DISCUSSION 
 In this study, of the 100 seropositive patients, 32 had neurological 
manifestations (32%). The incidence of neurological manifestations in HIV positive 
patients according to snider et al1 was 31% and levy et al2 was 39%. In India Gupta  
et al41 found an incidence of 25.75% in his study.  
AGE 
 Most  of the patients in this study were in the age group of 31 – 40 (59.38%). 
The mean age of the patients with neurological manifestations in a study in university 
of California and Sanfransisco data was 37.3 years38. Mean age in this study was 
35.63 years. 
SEX 
 Male patients were found to have neurological manifestations more common 
(90.63%) as against females (9.38%). Male to female ratio was approximately 9:1. 
Mehta et al has reported male predominance with male to female ratio of 12:1. 
OCCUPATION  
 High incidence of neurological manifestations was noted among daily wage 
labourers (37.50%), followed by drivers with 15.63%. Perhaps these patients more 
often seek medical help in government hospital and also because HIV infection rate 
are high in this group of patients. 
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MODE OF TRANSMISSION  
 All patients with neurological manifestations had heterosexual behaviour as the 
risk factor. None of our patients had homosexual relationship. Gupta et al41 found 
heterosexual relationship in 64.7%, 5.85% in drug abusers and blood transfusion in 
14.7%. 
PRE-EXISTING INFECTION  
 Tuberculous adenitis was present in one patient with tuberculous meningitis. 
Patient had enlarged cervical lymphnodes on presentation and was not on 
antiretroviral therapy. So, a possibility of immunomodulation syndrome was unlikely. 
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                                     CLINICAL PRESENTATION  
ALTERED SENSORIUM 
 This was the commonest presenting symptom in the study. 14 out of the 32 
patients, had altered sensorium (43.75%). Altered sensorium as observed in this study 
was primarily due to a meningeal infection, tuberculous meningitis being most 
frequent, followed by cryptococcal and pyogenic meningitis. None of the patients in 
this study had CNS lymphoma. University of California and Sanfransisco data 
revealed altered sensorium as a manifestation in secondary viral infection. Progressive 
multifocal leucoencephalopathy, toxoplasmosis, cryptococcosis, HIV dementia and 
lymphoma38. 
HEADACHE  
 13 of the 32 patients with neurological symptoms, presented with headache 
(40.63%). 11 patients (84.61%) had opportunistic infections like tuberculous 
meningitis, cryptococcosis and pyogenic meningitis as the cause. Two other patients 
had HIV dementia and multiple granulomata as the cause. 
 Headache is an extremely common symptom in HIV infection, because of the 
frequency of intracranial infection and mass lesions. CB Graham et al42 has described 
headache as a common symptom in HIV infection frequently. 
SEIZURES 
 In our study, the common cause for seizures was neurotuberculosis. Of the 32 
patients, 8 patients had seizures (25.00%). Two patients had normal CT brain and 
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C.S.F analysis did not reveal any abnormality. EEG in these patients showed bilateral 
epileptiform activity. 
 This is perhaps because approximately half the HIV infected patients have no 
definite identifiable disease of the brain and cerebral HIV infection seems to be the 
likely cause of the seizures, as reported by Holtzman et al study which had HIV 
encephalopathy as the cause of seizures in 24% of the patients43. 
PARAPARESIS 
 4 patients had paraparesis on presentation in our study (12.50%). Of the 4, 2 
were due Guillian - Barre syndrome, one due to HIV myelopathy and one had 
concomitant neurosyphilis.  
 Human T cell lymphotrophic virus 1, tuberculosis, herpes zoster and syphilis 
were the causes of paraparesis described by A.I Bhigjee et al in their study44. 
PARAESTHESIAS 
 Two patients in our study had paraesthesias of both lower limb (6.25%). 
Electrodiagnostic study done in these two patients showed slowing of sensory 
conduction of lower limb sensory nerves. Both the patients were on antiretroviral 
therapy (which included zidovudine) and improved with amitryptilline and nutritional 
support. 
 Gupta et al has shown an incidence of 8.82% of peripheral neuropathy in his 
study41. 
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CEREBELLAR SYNDROME 
 Of the 32 patients 2 had features of cerebellar syndrome (6.25%). One patient 
had an hypodense lesion in the cerebellar area in the CT brain (plain) and the other 
patient had VDRL positive both in C.S.F analysis and blood i.e associated 
neurosyphilis. 
 Mc Arthur et al had noticed gait disturbance and clumsiness in 45% of patients 
with HIV dementia45. Both our patients did not have associated dementia. 
INVOLUNTARY MOVEMENTS 
 One patient had involuntary movements in this study. He had abnormal 
semipurposive movements involving right upper limb and abnormal flinging 
movements of the lower limbs. MRI of the patient showed extensive white matter 
lesions. Patient was diagnosed as progressive multifocal leucoencephalopathy. PCR 
for JC virus however could not be done. 
 PITAGORAS DE MATTOS JAMES et al46 has showed an incidence of 2.7% 
for involuntary movements in HIV. Almost all  types of involuntary movements have 
been reported in HIV, of which the most common was secondary to parkinsonism. 
Comparative Table : 1 
 Bandyopadhyay et al This study 
Number of Patients 128 100 
Incidence 32.9 % 32 % 
Headache N.A 13 (40.63%) 
Altered sensorium 14 (8.9%) 14 ( 43.75% ) 
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Hemiplegia N.A 4 (12.50%) 
Seizues 17 (10.8%) 8 (25.0%) 
Paraparesis N.A 1 (3.13%) 
Paraesthesias N.A 2 (6.25%) 
Cerebellar Syndrome N.A 2 (6.25%) 
Involuntary Movements N.A 1 (3.13%) 
Psychosis 11 (6.3%) N.A 
* N.A -  Not available  
AIDS DEMENTIA COMPLEX 
 Among the 32 patients, one had AIDS dementia complex (3.13%). Patient 
presented with headache and progressive cognitive decline. Mini mental score of the 
patient was 22. CT brain and C.S.F analysis were normal. 
 Impaired memory and concentration with psychomotor slowing represent the 
common early presentation of this disorder. 
 Bandyopadhyay et al47 reported 21% incidence in their studies respectively. In 
view of these findings baseline MMSE is probably advisable for all cases with HIV 
seropositivity and periodic evaluation may unearth more cases with AIDS dementia 
complex. 
PERIPHERAL NEUROPATHY 
 In our study two patients had peripheral neuropathy (6.25%). Both the patients 
presented with paraesthesias and was taking antiretroviral therapy which included 
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zidovudine. Nerve conduction study in both these patients revealed slowing of 
sensory conduction at lower limb sensory nerves. 
 HIV associated sensory neuropathies include both distal sensory 
polyneuropathy due to HIV infection and antiretroviral toxicity. It is very difficult to 
differentiate between the two48. Treatment is largely symptomatic. Our patients 
improved with change of retroviral regimen, amitryptilline and nutritional support. 
MYOPATHY 
 One patient in our study had myopathy (3.13%). The patient presented with 
myalgia, proximal muscle weakness. On investigating further he had elevated 
creatinine kinase levels. Patient was on antiretroviral therapy, whether the myopathy 
was due to the primary infection or antiretroviral therapy could not be established as 
the patient refused a muscle biopsy. After stopping zidovudine patient was followed 
up, but showed no improvement in symptoms. 
 Studies have suggested that zidovudine induced myopathy occurs only when 
an underlying HIV related inflammatory myopathy is present49. 
HIV MYELOPATHY 
 Of the 32 patients in the study, one had HIV related myelopathy (3.13%). 
Patient had lower limb weakness and urinary incontinence on presentation. MRI spine 
showed no abnormalities and C.S.F analysis was normal. Vitamin B12 levels were 
done to rule out a secondary cause, which was also normal. 
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 Jerez.p et al50 have shown 22% incidence of spinal lesions in AIDS. Leading 
cause of myelopathies described in association with HIV was vacuolar myelopathy 
followed by myelitis. 
NEUROTUBERCULOSIS 
 11 out of 32 patients who had neurological symptoms in our study had 
tuberculous infection of the nervous system. Among the 11 patients, 10 had 
tuberculous meningitis (31.25%) and 1 had tuberculoma (3.13%). 9 of the 10 patients 
with tuberculous meningitis expired (90%). 
 The patient diagnosed with tuberculoma presented with headache and partial 
seizures involving left upper limb. MRI brain revealed multiple ring enhancing 
lesions. C.S.F analysis showed elevated protein with predominant lymphocytes. 
 Increased number of neurotuberculosis in Indian studies is probably due to the 
high prevalence of tuberculosis in this part of the world. 
 In all our patients tuberculous meningitis was the first manifestation of the 
disease. None of the patients were on antiretroviral therapy. 
PYOGENIC MENINGITIS 
 2 patients had features of pyogenic meningitis (6.25%). Both the patients 
presented with altered sensorium, fever and headache. CT brain was normal and C.S.F 
analysis revealed elevated proteins and predominant neutrophils in cytology. C.S.F 
culture did not grow any organism. 
 Both the patients however succumbed to the disease proving the point that 
pyogenic infection coexisting with HIV infection has very high mortality. 
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 AIDS related CNS complication from bacterial pathogens have not been 
reported from western studies. 
 Studies from third world countries, such as that of baingana et al51 from 
Uganda reported 7% incidence of bacterial meningitis. 
CRYPTOCOCCAL MANINGITIS 
 Of the 32 patients one had cryptococcal meningitis (3.13%). Headache, altered 
sensorium and signs of meningeal irritation was the presentation. C.S.F analysis in 
this patient was positive for Cryptococcus on India ink preparation. 
Bandypadhyay et al47 in his study had 3.7% incidence of cryptococcal 
meningitis. 
PROGRESSIVE MULTIFOCAL LEUCOENCEPHALOPATHY 
 One patient in our study was diagnosed to have progressive multifocal 
leucoencephalopathy (3.13%). The patient had involuntary movements involving right 
upper and lower limbs with memory loss on presentation. Mini mental score of the 
patient was 20. C.S.F analysis showed no abnormalities. MRI brain revealed 
extensive white matter lesions involving left caudate nucleas, capsuloganglionic 
region, bilateral parietal and occipital regions, with enhancement on T2W flair image. 
 Snider et al1 studied 50 patients with AIDS, in which he had 2 patients with 
progressive multifical leucoencephalopathy. 
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NEUROSYPHILIS 
 In our study one patient had concomitant neurosyphilis(3.13%). Patient 
presented with unsteady gait, bladder incontinence and subacute onset of paraparesis 
on admission. On examination patient had anisocoria with right pupil dilated 
exhibiting Argyll Robertson phenomenon. Blood and C.S.F VDRL was reactive ( 1 in 
64 dilutions and 1 in 8 dilutions respectively). C.S.F for  TPHA was positive. MRI of 
the spine was normal and nerve conduction studies in lower limbs was abnormal 
suggestive of polyradiculoneuropathy. 
 Bordon J et al52 studied 972 HIV seropositive patients over the period of 3.5 
years and found an incidence of 3.1% for concomitant neurosyphilis.   
CEREBROVASCULAR ACCIDENT 
 3 patients in our study presented with cerebrovascular complications (9.38%). 
All three patients presented with hemiparesis and their CT brain showed middle 
cerebral arterial territory infarct. One of the patient had a poor GCS (6/15). On 
admission and he expired on the same day. Evaluation of the other 2 for young stroke 
showed no abnormalities. 
 Gupta et al41 has reported 8.82% incidence of CVA in seropositive patients in 
his study. 
 There is a broad spectrum of etiologies causing this scenario but in many cases 
the pathogenesis is unclear. Cerebral granulomatous angitis due to HIV infection 
could result in vascular occlusive disease39 
. 
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GUILLIAN BARRE SYNDROME  
 Among the 32 patients with neurological symptoms, 2 had Guillian - Barre 
syndrome (6.25%). Both the patients presented with features of ascending paralysis. 
C.S.F analysis showed elevated protein with acellular smear cytology. Nerve 
conduction studies had features of axonal degeneration. Oligoclonal band in C.S.F 
could not be done. 
 HIV-GBS occurs in early and late stages of HIV infection, and may follow 
onset of AIDS. TH Brannagan et al53 had reviewed 10 patients with  HIV-GBS 
between 1986 and 1999, in which GBS was the first symptom of the HIV infection in 
3 patients. 
SEIZURE DISORDERS 
 Two patients in this study group presented as seizure disorder (6.25%). One 
patient presented with left focal seizure involving upper limb with secondary 
generalization and the other patient had generalized tonic clonic seizures. CT brain 
and C.S.F analysis were normal in both the patients. EEG showed bilateral 
epileptiform activity. 
 Approximately half of HIV infected patients with seizures have no definite 
identifiable disease of the brain and cerebral HIV infection seems to be the most 
likely cause of the seizures. It the study by Holtzman et al, HIV encephalopathy was 
responsible for seizures in 24% of the patients43.   
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MULTIPLE GRANULOMATA 
 In our study one patient presented with chronic headache of 2 years duration. 
CT brain done on the patient showed multiple calcified granulomas. C.S.F analysis 
revealed no abnormality. As the patient could not afford MRI brain was not done. 
Patient was empirically treated with albendazole with no apparent improvement on 
immediate follow up. 
MORTALITY 
 18 out of the 32 patients who had neurological manifestations expired in our 
study (56.25%). Half of the deaths were due to tuberculous meningitis (50.00%). 
 Morbidity and mortality in HIV/AIDS is well established. Co-existing 
neurological manifestations appear to significantly contribute to poor outcome. 
Comparative Table : 2 
 Gupta et al 
Bandyopadhyay 
et al 
Our study 
Year of Study 1993 2005 2006 
Incidence 25.75% 32.9% 32% 
Mode of transmission Heterosexual - 64.5% 
I.V Drug abuser - 
5.85 % 
Blood transfusion - 
14.7 % 
 
 
N.A 
 
 
Heterosexual - 
100% 
AIDS dementia 
complex 
17.65% 13.3% 3.13% 
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Peripheral neuropathy 8.82% 8.2% 6.25% 
Neurotuberculosis 58.82% 12.1% 31.25% 
Cryptococcal 
meningitis 
8.8% 6.0% 3.13% 
Neurosyphilis N.A N.A 3.13% 
PML N.A N.A 3.13% 
Myopathy N.A N.A 3.13% 
Toxoplasmosis 3.8% 2.5% - 
CVA 8.82% N.A 9.38% 
Seizure disorder N.A N.A 6.25% 
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Figure - 1 : MRI Brain showing extensive white matter lesions (PML) 
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Figure - 2 : MRI Brain (Saggital section) showing extensive white matter  
lesions (PML) 
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Figure - 3 : MRI Brain showing ring enhancing lesions (Tuberculoma) 
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Figure - 4 : MRI Brain (saggital section) showing ring enhancing lesions 
(Tuberculoma) 
 52
CONCLUSIONS 
1. Incidence of neurological illness in HIV infection in our study was 32%. 
2. Altered mentation and seizures were the two common symptoms observed in 
this study. 
3. All patients in our study had heterosexual transmission of disease. 
4. CNS manifestations in men were more common than in women. 
5. Tuberculous meningitis was the most commonest opportunistic infection in our 
study. 
6. No significant CD4 count correlation was found between the patients with 
neurological manifestations and those without neurological manifestations. 
7. Patients with neurological manifestations had high mortality and poor 
outcome. 
8. Tuberculous and pyogenic meningitis were associated with very high 
mortality. 
9. CD4 count when less was associated with increased mortality. 
10. Patients with coexisting tuberculous meningitis and HIV injury had 
significantly lower CD4 counts.   
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SUMMARY 
 Of the 100 patients 32 had neurological manifestations.  
 Following were the neurological manifestations : Tuberculous 
meningitis(31.25%), cerebrovascular complications(9.38%), Guillian barre syndrome 
(6.25%), pyogenic meningitis (3.13%), peripheral neuropathy (6.25%), seizure 
disorders (6.25%), acute flaccid paralysis (3.13%), AIDS dementia complex (3.13%), 
cerebellar syndrome (3.13%), cryptococcal meningitis (3.13%), HIV myelopathy 
(3.13%), meningoencephalitis – cause not determined (3.13%), multiple granulomata 
(3.13%), myopathy (3.13%), neurosyphilis (3.13%), progressive multifocal 
leucoencephalopathy (3.13%), Tuberculoma (3.13%). 
 Mortality increased most with coexisting Tuberculosis and with decreased CD4 
counts. 
 Commonest neurological condition associated was neurotuberculosis.  
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PROFORMA 
 
Name :    Age :     Sex : 
 
Place :    Occupation :    Date of Admission : 
  
Hospital No :       Date of Discharge : 
 
 
PRESENTING COMPLAINTS : 
 
Past History :   Yes   No 
 
Diabetes Mellitus 
 
Hypertension 
 
H/O Tuberculosis 
 
H/O Exposure to a case of tuberculosis 
 
 
PERSONAL HISTORY : 
 
Marital Status : 
 
Diet :    Appetite :   Sleep :  
 
Bowel :   Bladder : 
 
Habit :    Alcohol   Yes  No 
 
    Smoking   Yes  No 
  
    Tobacco Chewing  Yes  No 
 
 
RISK FACTORS YES NO 
Heterosexual   
Homosexual   
I.V drug abuser   
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GENERAL PHYSICAL EXAMINATION : 
 
Built & Nourishment : 
 
Pallor :    Icterus :   Cyanosis : 
 
Clubbing : 
 
Pedal edema :   Lymph nodes : 
 
Oral Candidiasis : 
 
Herpes Zoster : 
 
Glossitis : 
 
VITAL SIGNS : 
 
Pulse : 
 
Blood Pressure : 
 
Temperature : 
 
Respiratory Rate : 
 
Weight : 
 
NERVOUS SYSTEM EXAMINATION : 
 
HIGHER MENTAL FUNCTIONS : 
 
MINI MENTAL STATE EXAMINATION SCORE : 
 
CRANIAL NERVES : 
 
FUNDUS : 
 
MOTOR SYSTEM EXAMINATION :  UPPER LIMB 
 
       LOWER LIMB 
 
REFLEXES :  SUPERFICIAL REFLEXES 
 
  DEEP TENDON REFLEXES 
 
CO-ORDINATION : 
 
INVOLUNTARY MOVEMENTS : 
 
SENSORY SYSTEM EXAMINATION : 
 
PRIMITIVE REFLEXES : 
 63
SIGNS OF MENINGEAL IRRITATION : 
 
GAIT : 
 
SKULL & SPINE : 
 
PERIPHERAL NERVES : 
 
OTHER SYSTEMS :  CVS 
 
   RS 
 
   PA 
 
INVESTIGATIONS : 
 
Hb 
TC 
DC 
ESR 
Urine Routine 
LFT 
RFT 
Serum Electrolytes 
Blood Sugar 
Chest X-Ray 
 
Sputum Examination 
 
CEREBROSPINAL FLUID STUDY : 
 
Cell - Count 
 Type 
 
Proteins 
 
Sugar 
 
Staining 
 
Culture 
 
Others 
 
SPECIAL INVESTIGATIONS: 
 
FINAL DIAGNOSIS : 
 
COURSE IN THE HOSPITAL 
 
ABBREVIATIONS 
 
ADL  - Activity of daily living 
AIDP - Acute inflammatory demyelinating polyneuropathy 
AIDS - Acquired immunodeficiency syndrome 
CIDP - Chronic inflammatory demyelinating polyneuropathy 
CMV - Cytomegalovirus 
CNS - Central nervous system 
CSF - Cerebrospinal fluid 
CVA - Cerebrovascular Accident  
ddI - dideoxyinosine 
ddC - dideoxycytidine 
d4T - Stavudine  
DSP - Distal symmetric polyneuropathy 
ELISA - Enzyme linked immunosorbant assay 
GBS - Guillian - Barre Syndrome 
HAM - HIV associated myelopathy 
HIV - Human immunodeficiency virus 
HTLV-1 - Human 'T' cell lymphotropic virus 
HSV - Herpes simplex virus 
IFA - Immunofluoroscence assay 
IL - Interleukin 
JC - Cruezfeld Jacob 
MRI - Magnetic resonance imagining   
MM - Mononeuropathy multiplex 
NACO - National AIDS Control Organization 
NCV - Nerve conduction velocity 
PCR - Polymerase chain reaction 
PCNSL - Primary CNS Lymphoma 
PP - Progressive polyradiculopathy 
PML - Progressive multifocal leucoencephalopathy 
TBM - Tuberculous meningitis 
T2WIs - T2 weighted images 
TNF - Tumour necrosis factor 
TGF - Transforming growth factor  
VM - Vacuolar myelopathy 
 
S.No Name Age Sex Occ M.O.T C.I. P.A.S H A.S Hem S P Q Pa CS I.M CD4 MMSE F C.S.F CT MRI Diagnosis
1 Sumithra 28 F H.W H.S. - W - - - - - - - - - 164 28
2 Jayavel 36 M D.L H.S. - A - - - - - - - - - 176 27
3 Elango 38 M D.L H.S. - W - - - - - - - - - 224 26
4 Chandran 37 M AGR H.S. - W - - - - - - - - - 211 26
5 Upendran 27 M STU H.S. PTB A - - - - - - - - - 50 25
6 Damotharan 38 M D.L H.S./I.V - A - - - - - - - - - 80 26
7 Venkatesh 41 M D.L H.S. - A - + - - - - - + - - N LCI Cerebellar Syndrome
8 Neethu 38 F H.W H.S. - W - - - - - - - - - 285 28
9 Ponamma 25 F D.L H.S. - W - - - - - - - - - 366 28
10 Vijayakumar 32 M DRV H.S. - B - + + - - - - - - -     - P MCAI CVA
11 Arun Kumar 29 M DRV H.S. - A - - - - - - - - - 261 27
12 Manimozhi 50 M D.L H.S. - W - - - - - - - - - 171 26
13 Natranajan 35 M BSN H.S. - A - - - - - - - - - 136 26
14 Edukondalu 21 M D.L H.S. TBA A - + - + - - - - - 124    - N EP , PL N TB Meningitis
15 Rajeshwari 32 F H.W H.S. - W + - - - - - - - - 289 27 P N MCG Multiple Granoloma
16 Vijay 33 M P H.S. - W - - - - - - - - - 177 26
17 Dilip 40 M D.L H.S. - W - - - - - - - - - 346 27
18 Murugesh 38 M AGR H.S. - A +  + - - - - - - - 89  - EP , PL N TB Meningitis
19 Jothi 25 F H.W H.S. - W -  - - - - - - - - 200 28
20 Zakir Hisian 35 M DRV H.S. - A - - - - + - - + - 529 24 N N N-msNeurosyphilis
21 Ravi 45 M P H.S. - W - - - - -  - - - - 213 27
22 Kumar 35 M D.L H.S. - A - - - - -  + - - -  - N N NPH ACUTE FLACCID PARALYSIS
23 Nethaji 38 M D.L H.S. - W - - - - - - - - - 65 26
24 Lakshmipathi 33 M D.L H.S. - A - - + - - - - - - 194 26 N MCAI CVA
25 Valiban 41 M UE H.S. - A - - - - + - - - - 176 27 N N N-msHIV Myelopathy
26 Uyusufkhan 41 M D.L H.S. - W - - - - - - - - - 184 26
27 Ravikumar 35 M DRV H.S. - A - - - - - - - - - 253 27
28 Vadivelu 32 M D.L H.S. - A - + - - - - - - - 142   - N EP , PL N TB Meningitis 
29 Venkatammal 40 F H.W H.S. - W - - - - - - - - - 178 28
30 Chandrasekar 36 M P H.S. - B + + - - - - - - - 94    - P EP , PL N TB Meningitis 
31 Vediyappan 28 M D.L H.S. - W - - - - - - - - - 220 28
32 Sumathi 20 F H.W H.S. - A - - - - - - - - - 291 26
33 Selvaraj 38 M P H.S. - W - - - - - - - - - 286 27
34 Muthuraman 56 M D.L H.S. - B - - - + - - - - - 177 26 N N N Seizure Disorder
35 Velarmathy 30 F H.W H.S. - W - - - - - - + - - 365 27 N Peripheral Neuropathy
36 Vivekannan 48 M D.L H.S. - A + + - - - - - - - 125     - P EP , PL N TB Meningitis
37 Amudha 45 F D.L H.S. - W - - - - - - - - - 251 26
38 Kumar 40 M P H.S. - A - - - - - - - - - 257 25
39 Suresh 35 M MEC H.S. - A - - - - - - - - - 114 26
40 Muthusamy 38 M D.L H.S. - A + - - - - - - - - 136 24 N EP , PL N TB Meningitis
41 Paranjothy 36 M P H.S. - W - - + - - - - - - 206 26 N MCAI CVA
42 Kasthuri 30 F D.L H.S. - A - - - - - - - - - 285 27
43 Subharao 34 M MEC H.S. - W - - - - - - - - - 206 27
44 Jayaraj 48 M D.L H.S. - W - - - - - - - - - 253 26
45 Ithayan 40 M AGR H.S. - A - - - - - - - - - 204 25
46 Rajalakshmi 29 F H.W H.S. - W - - - - + - - - - 176 26 N EP ,A GBS
47 Ramesh 32 M DRV H.S. - W -  - - - - - - - - 236 27
48 Sekar 27 M DRV H.S. - A - + + + - - - - - -  - EP ,PL N TB Meningitis
49 Kesavan 43 M MEC H.S. - A - - - - - -  - - - 254 24 N Myopathy
50 Alamelu 30 F D.L H.S. - W - - - - - - - - - 128 26
51 Valli 27 F H.W H.S. - W - - - - - - - - - 161 27
52 manickam 37 M DRV H.S. - W - - - - - - - - - 513 28
53 Suresh 28 M P H.S. - A - - - - - - - - - 102 26
54 Lakshmanan 36 M D.L H.S. - W - - - - - - - - - 173 27
55 Fathima 24 F H.W H.S. - W - - - - - - - - - 192 28
56 Balaiah 40 M P H.S. - W - - - - - - + - - 410 28 N Peripheral Neuropathy
57 Jayapal 43 M DRV H.S. - A - - - - - - - - - 71 27
58 Susmitha 23 F ACC H.S. - W - - - - - - - - - 254 26
59 Selvi 29 F H.W H.S. - W - - - - - - - - - 210 27
60 Raja 40 M DRV H.S. - W - - - - - - - - - 171 27
61 Vijayan 37 M UE H.S. - A - + - + - - - - - -  - N MENINGOENCEPHALITIS
62 Ratchagan 35 M DRV H.S. - W - - - - + - - - - 215 25 N EP , A GBS
63 Vadivelu 41 M P H.S. - W - - - - - - - - - 111 27
64 Murugan 57 M BSN H.S. - W - - - - - - - - - 282 26
65 Saraswathy 27 F H.W H.S. - A - - - - - - - - - 210 28
66 Ramana 32 M D.L H.S. - W - - - - - - - - - 193 27
67 Baskar 31 M D.L H.S. - A + - - + - - - - - 54 22 N EP , PL N TB Meningitis
68 Murugeshan 42 M P H.S. - A + + - - - - - - - 126 23 N EP ,OL , I.I+ N Crptococcal Meningitis 
69 Rajendran 41 M DRV H.S. - W - - - - - - - - - 134 27
70 Abdul Hamaal 45 M BSN H.S. - W - - - - - - - - - 101 26
71 Meyyan 36 M D.L H.S. - A - - - - - - - - - 241 27
72 Dinesh 41 M D.L H.S. - A + + - - - - - - - 116 P EP , PN N Pyogenic Meningitis
73 Hemavathi 26 F H.W H.S. - W - - - - - - - - - 262 26
74  Veerasamy 40 M BSN H.S. - W - - - - - - - - - 98 27
75 Thailammal 32 F AGR H.S. - A - - - - - - - - - 126 28
76 Kasinathan 45 M UE H.S. - B + - - + - - - - - 186 26 N EP ,PL N MRE Tuberculoma
77 Louis 35 M DRV H.S. - A - - - - - - - - - 339 27
78 Amudha 36 F H.W H.S. - W - - - - - - - - - 1090 27
79 Kumar 32 M D.L H.S. - W + + - - - - - - - 210 N EP,PL N TB Meningitis
80 Rangan 50 M D.L H.S. - A - - - - - - - - - 77 26
81 Ramesh 37 M DRV H.S. - A - - - - - - - - - 182 27
82 Jayaraman 32 M P H.S. - W - - - - - - - - - 252 25
83 Munusamy 35 M AGR H.S. - A - - - - - - - - + 9 20 N N EWL PML
84 Amsavel 34 M AGR H.S. - W + - - - - - - - - 54 22 HR N N AIDS Dementia Complex
85 Chandru 36 M P H.S. - W - - - - - - - - - 325 26
86 Raju 38 M D.L H.S. - A - - - - - - - - - 250 27
87 PeriyaSamy 42 M AGR H.S. - W - - - - - - - - - 226 26
88 Palani 32 M D.L H.S. - A + + - - - - - - - 114 P EP , PL N TB Meningitis
89 Deepa 28 F P H.S. - W - - - - - - - - - 324 27
90 Bashir 35 M DRV H.S. - A - - - - - - - - - 189 26
91 Rajammal 32 F H.W H.S. - W - - - - - - - - - 292 28
92 Ilavarasi 34 F AGR H.S. - W - - - - - - - - - 186 27
93 Rajkumar 29 M D.L H.S. - W - - - - - - - - - 326 26
94 Ashok Kumar 36 M MEC H.S. - A + + - + - - - - - 104 N EP , PN N pyogenic meningitis
95 Gandhi Madhi 40 F H.W H.S. - W - - - - - - - - - 224 27
96 Suresh Kumar 23 M DRV H.S. - W - - - + - - - - - 164 26 N N N Seizure disorder
97 Vedaiya 34 M P H.S. - W - - - - - - - - - 294 25
OutCome 
Expired
Expired
Expired
StatusQuo
Expired
Status Quo
Expired
Improved
StatusQuo
Expired
Expired
Status Quo
Improved 
Expired
Expired
Status Quo
Expired
Expired
Statis Quo
Improved
Expired
Status Quo
Expired
Expired
Expired
Status Quo
Improved
Expired
Status Quo
Expired
Expired
Improved 
F - Female Hem - Hemiplegia
M - Male S - Seizures
AGR - Agriculture P - Paraparesis
D.L Daily Labourer Q - Quadriparesis
DRV - Driver Pa Paraesthesias
H.W House Wife CS - Cerebellar Syndrome
MEC - Mechanic I.M Involuntary Movements
P - Painter MMSE - Mini mental score examination
UE - Unemployed F - Fundus
STU - Student C.S.F - Cerebrospinal fluid analysis
BSN - Business N - Normal
ACC - Accountant P - Pappilloedema
H.S - Heterosexual EP, PL - Elevated proteins, Predominant lymphocytes
I.V Intravenous drug abuser EP, A Elevated proteins, acellular
PTB Pulmonary Tuberculosis EP, PN - Elavated proteins, Predominant neutrophils
TBA - Tuberculous adenitis EP, OL, I.I+Elevated proteins, Occational lymphocytes, India ink positive
W - Working MCAI - Middle Cerebral arterial territory infarct
A - Ambulatory MCG - Multiple calcified granuloma
B - Bedridden EWL - Extensive White Matter lesions
H - Headache MRE - Multiple Ring enhancing lesions
AS - Altered Sensorium NPH - Normal pressure hydrocephalus
N-ms Normal MRI spine
